$6.16
-0.18 (-2.84%)
Open$6.32
Previous Close$6.34
Day High$6.38
Day Low$6.03
52W High$13.50
52W Low$3.25
Volume—
Avg Volume95.7K
Market Cap77.44M
P/E Ratio—
EPS$-3.18
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+206.4% upside
Current
$6.16
$6.16
Target
$18.86
$18.86
$15.04
$18.86 avg
$28.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 259.4K | 344.9K | 28.89M |
| Net Income | -33,923,849 | -40,589,556 | 2.55M |
| Profit Margin | -13,086.5% | -12,432.2% | 8.8% |
| EBITDA | -27,980,658 | -35,338,507 | 4.88M |
| Free Cash Flow | — | — | 2.44M |
| Rev Growth | -24.8% | -24.8% | +0.1% |
| Debt/Equity | 1.99 | 1.99 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |